Literature DB >> 27639494

[Reproducibility of visual acuity measurement using the ETDRS chart in daily clinical practice].

C Nicolas1, G Debellemanière1, F Boissier1, C Girard1, C Schwartz1, B Delbosc1, M Saleh2.   

Abstract

OBJECTIVE: To evaluate reproducibility of visual acuity measurements using the ETDRS chart at successive monthly visits in patients with stable macular pathology.
MATERIALS AND METHODS: Visual acuity was measured using the ETDRS chart at 6 consecutive monthly examinations. Relative standard deviation of visual acuity was measured for every patient. Analysis of the results by type of pathology, age, sex and examiner experience was performed.
RESULTS: One hundred and three patients were included. Mean patient age was 72.7±12.4 years. A total of 68.9% of the patients suffered from AMD. Mean visual acuity was 47.4±9.5 ETDRS letters. Mean reproducibility of the measurement estimated by relative standard deviation over the 618 examinations was 5.4±2.8% (CI95%: 4.9-6%) with extremes values of 0.4 and 7.8 letters. Relative standard deviation corresponding to the mean ETDRS score (47.4 letters) was 2.5 letters. Reproducibility of visual acuity measurement was better in patients under 76 years, pseudophakes, or with a visual acuity better than 50 letters (P<0.05). Variability of the measurement increased with age (r2=13%, P=0.001) and with low visual acuity (r2=35%, P<0.0001) and was larger in patients suffering from AMD than those suffering from other conditions. Examiner experience did not seem to influence reproducibility of the measurement.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Acuité visuelle; ETDRS; Maculopathie; Maculopathy; Reproducibility; Reproductibilité; Visual acuity

Mesh:

Year:  2016        PMID: 27639494     DOI: 10.1016/j.jfo.2016.03.007

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Real-Life Value of the Odysight® Application in At-Home Screening for Exudative Recurrence of Macular Edema.

Authors:  Gauthier Kielwasser; Laurent Kodjikian; Corinne Dot; Carole Burillon; Philippe Denis; Thibaud Mathis
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.